Thomas Kim

Insider Reports History

Entity
Individual
Location
C/O Enfusion Inc., 125 South Clark St., Suite 750, Chicago, IL
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enfusion, Inc. Chief Executive Officer, Director Class A Common Stock 866K $7.49M $8.65 Jun 15, 2022 Direct
Enfusion, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 32K Jun 15, 2022 Direct

Insider Reports Filed by Thomas Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENFN Enfusion, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Chief Executive Officer, Director
ENFN Enfusion, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Chief Executive Officer, Director